Publications
Publications
- September 2005 (Revised June 2006)
- HBS Case Collection
WuXi PharmaTech
By: Richard G. Hamermesh and Simin Zhou
Abstract
WuXi Pharmatech has gone from zero to $21 million in sales in three years. The company must decide its growth strategy and how best to finance and organize for rapid growth.
Keywords
Citation
Hamermesh, Richard G., and Simin Zhou. "WuXi PharmaTech." Harvard Business School Case 806-003, September 2005. (Revised June 2006.)